138 related articles for article (PubMed ID: 9207466)
1. RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
Li YP; Andersen J; Zelent A; Rao S; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
Blood; 1997 Jul; 90(1):306-12. PubMed ID: 9207466
[TBL] [Abstract][Full Text] [Related]
2. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
3. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells.
Raelson JV; Nervi C; Rosenauer A; Benedetti L; Monczak Y; Pearson M; Pelicci PG; Miller WH
Blood; 1996 Oct; 88(8):2826-32. PubMed ID: 8874178
[TBL] [Abstract][Full Text] [Related]
4. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid.
Gallagher RE; Li YP; Rao S; Paietta E; Andersen J; Etkind P; Bennett JM; Tallman MS; Wiernik PH
Blood; 1995 Aug; 86(4):1540-7. PubMed ID: 7632962
[TBL] [Abstract][Full Text] [Related]
5. Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
Gallagher RE; Willman CL; Slack JL; Andersen JW; Li YP; Viswanatha D; Bloomfield CD; Appelbaum FR; Schiffer CA; Tallman MS; Wiernik PH
Blood; 1997 Aug; 90(4):1656-63. PubMed ID: 9269786
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
[TBL] [Abstract][Full Text] [Related]
7. Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.
Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP
Blood; 1996 Nov; 88(10):3926-36. PubMed ID: 8916959
[TBL] [Abstract][Full Text] [Related]
8. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Am J Hematol; 1994 Mar; 45(3):212-6. PubMed ID: 8296791
[TBL] [Abstract][Full Text] [Related]
9. [Expression of survivin gene in NB4 cell line and cells of acute promyelocytic leukemia and its anti-apoptosis and clinical significance].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):332-6. PubMed ID: 16638209
[TBL] [Abstract][Full Text] [Related]
10. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
[TBL] [Abstract][Full Text] [Related]
11. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
Chen GQ; Zhu J; Shi XG; Ni JH; Zhong HJ; Si GY; Jin XL; Tang W; Li XS; Xong SM; Shen ZX; Sun GL; Ma J; Zhang P; Zhang TD; Gazin C; Naoe T; Chen SJ; Wang ZY; Chen Z
Blood; 1996 Aug; 88(3):1052-61. PubMed ID: 8704214
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
14. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
15. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells.
Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E
Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041
[TBL] [Abstract][Full Text] [Related]
16. The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.
Müller C; Yang R; Park DJ; Serve H; Berdel WE; Koeffler HP
Blood; 2000 Dec; 96(12):3894-9. PubMed ID: 11090075
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
18. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
[TBL] [Abstract][Full Text] [Related]
19. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
20. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.
Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E
Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]